argenx SE
ongoing robust phase first in human study | argenx SE
Company
Deck Type
Sector
Industry
Deck date
July 2021
Slide
56 of 69
Related slides by other companies
Exscientia
Results
March 2024
elucidate phase ongoing in advanced solid | Exscientia
MindMed
Investor Presentation
November 2024
for gad phase study designs voyage panorama | MindMed
Erasca
Investor Presentation
November 2023
clinical activity of in melanoma was reproducible across phase and phase studies a | Erasca
MindMed
Investor Presentation
December 2024
phase trial schematic schematic week a dose optimization study of | MindMed
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights